StocksInsider desk· Jul 23
ON Semiconductor Buys Synaptics for $7 Billion
ON Semiconductor expands its AI-enabled devices portfolio with a $7 billion all-stock acquisition of Synaptics.
Read the full story →From the archiveRead today's paper →
Thursday Jul 23, 2026
StocksInsider desk· Jul 23
ON Semiconductor expands its AI-enabled devices portfolio with a $7 billion all-stock acquisition of Synaptics.
Read the full story →Merck KGaA has announced its acquisition of Bio-Techne for $11.3 billion, marking its largest deal in over a decade. The acquisition is a strategic move to enhance Merck's capabilities in complex drug research and manufacturing tools, reflecting the company's focus on expanding its biopharmaceutical portfolio.
Amphenol has finalized its $10.5 billion acquisition of CommScope's Connectivity and Cable unit. This acquisition is a significant shift in Amphenol's portfolio, aimed at strengthening its position in the communications components market.
HNI has agreed to acquire Steelcase for $2.2 billion, consolidating the office-furniture manufacturing sector amid evolving post-pandemic workspace demand. This merger positions HNI to better serve a changing market landscape.
MarketsMarket wrap· Jul 23
Nasdaq Composite declines on tech sector pressure ahead of earnings, while Dow Jones outperforms with value and cyclicals.
Read the full story →Brent crude prices are approaching $100 per barrel, driven by escalating geopolitical tensions in the Middle East. This rise in oil prices is impacting global inflation expectations and energy-importing economies.
Gold ticked higher as investors sought hedges against geopolitical risk and higher oil-linked inflation expectations. Despite firm real yields, gold remains a favored safe-haven asset amid rising uncertainty.
The Nasdaq Composite is under pressure as traders de-risk ahead of major tech earnings from companies like Alphabet and Tesla. Software and growth names are particularly affected by this cautious stance.
BondsRates & credit· Jul 23
U.S. Treasury yields remain elevated, reflecting inflation concerns driven by rising oil prices and firm real yields.
Read the full story →Fed-funds futures indicate a 'higher for longer' rate path, with limited expectations for near-term cuts. This stance is driven by resilient economic activity and persistent inflation pressures.
U.S. investment-grade and high-yield credit spreads remained relatively contained, supported by solid earnings and robust risk appetite. M&A activity and leveraged-buyout headlines are adding dispersion to the market.
European sovereign yields are firm as traders monitor ECB guidance amid energy shocks and political uncertainty. Persistent core inflation is influencing bond market dynamics in the region.
GeopoliticsGeo desk· Jul 23
Escalating conflict in the Middle East pushes oil prices higher, altering global inflation and growth expectations.
Read the full story →European regulators have granted antitrust approval for Paramount Skydance's $110 billion acquisition of Warner Bros Discovery. The decision underscores regulatory willingness to clear large media deals with certain concessions.
The European Commission has raised objections to JD.com's acquisition of Ceconomy. This highlights increased EU oversight of Chinese corporate expansion in strategic retail channels.
Switzerland's highest court has ordered a fresh ruling in a case tied to leaked bank data exposing the cum-ex tax fraud scandal. This decision keeps European financial-crime risk in focus.
MemesThe tape, unhinged· Jul 23
Zhongchao Inc. leads gainers with a 192% increase, while Wetour Robotics plummets 82% on NASDAQ.
Read the full story →PN Smart Energy Limited's stock surged 132% to $9.34, marking it as one of the top gainers on NASDAQ. The company is drawing significant attention from market participants.
Lakewood-Amedex Biotherapeutics Inc. saw its stock price rise 83% to $3.41. The company's performance is indicative of the biotech sector's volatility.
Advanced Biomed Inc.'s stock climbed 73% to $12.25. This rise is part of a broader trend of gains within the biotech and healthcare sectors.